These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 24412445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A.
    Circulation; 2014 Jun 24; 129(25):2638-44. PubMed ID: 24744272
    [Abstract] [Full Text] [Related]

  • 4. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A.
    J Am Coll Cardiol; 2012 Mar 27; 59(13):1168-74. PubMed ID: 22305113
    [Abstract] [Full Text] [Related]

  • 5. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
    Di Biase L, Lakkireddy D, Trivedi C, Deneke T, Martinek M, Mohanty S, Mohanty P, Prakash S, Bai R, Reddy M, Gianni C, Horton R, Bailey S, Sigmund E, Derndorfer M, Schade A, Mueller P, Szoelloes A, Sanchez J, Al-Ahmad A, Hranitzky P, Gallinghouse GJ, Hongo RH, Beheiry S, Pürerfellner H, Burkhardt JD, Natale A.
    Heart Rhythm; 2015 Jun 27; 12(6):1162-8. PubMed ID: 25728754
    [Abstract] [Full Text] [Related]

  • 6. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Providência R, Marijon E, Albenque JP, Combes S, Combes N, Jourda F, Hireche H, Morais J, Boveda S.
    Europace; 2014 Aug 27; 16(8):1137-44. PubMed ID: 24550347
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin.
    Tao S, Otomo K, Ono Y, Osaka Y, Hirao T, Koura K, Manno T, Ueshima D, Shimizu S, Isobe M, Hirao K.
    J Interv Card Electrophysiol; 2017 Mar 27; 48(2):167-175. PubMed ID: 27943112
    [Abstract] [Full Text] [Related]

  • 8. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW.
    J Am Coll Cardiol; 2013 Feb 12; 61(6):651-8. PubMed ID: 23391196
    [Abstract] [Full Text] [Related]

  • 9. Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.
    Naccarelli GV, Cappato R, Hohnloser SH, Marchlinski FE, Wilber DJ, Xiang J, Ma C, Hess S, Davies DW, Fields LE, Natale A, VENTURE-AF Investigators.
    J Interv Card Electrophysiol; 2014 Nov 12; 41(2):107-16. PubMed ID: 25005452
    [Abstract] [Full Text] [Related]

  • 10. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL, Lindsley JP, Moranville MP, Habibi M, Khurram IM, Spragg DD, Berger RD, Calkins H, Marine JE.
    Ann Pharmacother; 2015 Mar 12; 49(3):278-84. PubMed ID: 25515868
    [Abstract] [Full Text] [Related]

  • 11. Rivaroxaban for Periprocedural Anticoagulation Therapy in Japanese Patients Undergoing Catheter Ablation of Paroxysmal Non-Valvular Atrial Fibrillation.
    Kawabata M, Sasaki T, Maeda S, Shirai Y, Yamauchi Y, Nitta J, Goya M, Hirao K.
    Int Heart J; 2016 Dec 02; 57(6):712-716. PubMed ID: 27818480
    [Abstract] [Full Text] [Related]

  • 12. Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter.
    Yadlapati A, Groh C, Passman R.
    Am J Cardiol; 2014 Apr 15; 113(8):1362-3. PubMed ID: 24576547
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
    Aryal MR, Ukaigwe A, Pandit A, Karmacharya P, Pradhan R, Mainali NR, Pathak R, Jalota L, Bhandari Y, Donato A.
    Am J Cardiol; 2014 Aug 15; 114(4):577-82. PubMed ID: 24998087
    [Abstract] [Full Text] [Related]

  • 14. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
    Eitel C, Koch J, Sommer P, John S, Kircher S, Bollmann A, Arya A, Piorkowski C, Hindricks G.
    Europace; 2013 Nov 15; 15(11):1587-93. PubMed ID: 23703362
    [Abstract] [Full Text] [Related]

  • 15. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
    Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, Ma CS, Hess S, Wells DS, Juang G, Vijgen J, Hügl BJ, Balasubramaniam R, De Chillou C, Davies DW, Fields LE, Natale A, VENTURE-AF Investigators.
    Eur Heart J; 2015 Jul 21; 36(28):1805-11. PubMed ID: 25975659
    [Abstract] [Full Text] [Related]

  • 16. Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry.
    Di Biase L, Briceno DF, Trivedi C, Mohanty S, Gianni C, Burkhardt JD, Mohanty P, Bai R, Gunda S, Horton R, Bailey S, Sanchez JE, Al-Ahmad A, Hranitzky P, Gallinghouse GJ, Reddy YM, Zagrodzky J, Hongo R, Beheiry S, Lakkireddy D, Natale A.
    Heart Rhythm; 2016 Jun 21; 13(6):1197-202. PubMed ID: 26994940
    [Abstract] [Full Text] [Related]

  • 17. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
    Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
    Europace; 2014 Oct 21; 16(10):1443-9. PubMed ID: 25115168
    [Abstract] [Full Text] [Related]

  • 18. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
    Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A.
    Circulation; 2010 Jun 15; 121(23):2550-6. PubMed ID: 20516376
    [Abstract] [Full Text] [Related]

  • 19. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.
    Yanagisawa S, Inden Y, Fujii A, Ando M, Funabiki J, Murase Y, Takenaka M, Otake N, Ikai Y, Sakamoto Y, Shibata R, Murohara T.
    JACC Clin Electrophysiol; 2018 May 15; 4(5):592-600. PubMed ID: 29798785
    [Abstract] [Full Text] [Related]

  • 20. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T, Abe M, Yamaki M, Fujieda H, Abe Y, Hashimoto K, Ishiba M, Sakai H, Hishikari K, Takigawa M, Okubo K, Takagi K, Tanaka Y, Nakajima J, Takahashi A.
    J Cardiovasc Electrophysiol; 2016 May 15; 27(5):549-54. PubMed ID: 26766541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.